May 13, 2019 Update: The working group recommendations regarding the Cuvitru brand shortage are available here.
Subcutaneous immune globulin (SCIG) is a blood product licensed in Canada for the treatment of patients with primary immunodeficiency disease. Unlike IVIG, which is infused in a hospital, SCIG can be infused at home by a patient who has been trained.
This section provides templates for health authorities to develop and customize their own SCIG program.
|
|
SCIG Resource Kit |
|
Under Review | |
Under Review | |
Training Materials | |
Under Review | |
Under Review | |
Under Review | |
Patient Handouts |
|
Under Review | |
Under Review | |
Form and Letter Templates |
|
Under Review | |